{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:42:50Z","timestamp":1791178970458,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":5425,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1111\/j.1538-7836.2008.02841.x","type":"journal-article","created":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T11:29:41Z","timestamp":1239794981000},"page":"268-276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Thrombin activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children"],"prefix":"10.1016","volume":"6","author":[{"given":"M.","family":"EMONTS","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.L.E.","family":"DE BRUIJNE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.H.C.","family":"GUIMAR\u00c3ES","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.J.","family":"DECLERCK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.W.G.","family":"LEEBEEK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.P.M.","family":"DE MAAT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.C.","family":"RIJKEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"HAZELZET","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"GILS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0010","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/adc.85.5.386","article-title":"Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery","volume":"85","author":"Booy","year":"2001","journal-title":"Arch Dis Child"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0015","doi-asserted-by":"crossref","first-page":"21833","DOI":"10.1016\/S0021-9258(18)54713-X","article-title":"Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma","volume":"266","author":"Eaton","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0020","doi-asserted-by":"crossref","first-page":"14477","DOI":"10.1074\/jbc.270.24.14477","article-title":"Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor","volume":"270","author":"Bajzar","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0025","doi-asserted-by":"crossref","first-page":"27176","DOI":"10.1074\/jbc.273.42.27176","article-title":"A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor","volume":"273","author":"Wang","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0030","doi-asserted-by":"crossref","first-page":"14477","DOI":"10.1074\/jbc.272.22.14477","article-title":"On the mechanism of the antifibrinolytic activity of plasma carboxypeptidase B","volume":"272","author":"Sakharov","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1172\/JCI0212119","article-title":"Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life","volume":"109","author":"Nagashima","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0040","doi-asserted-by":"crossref","first-page":"6764","DOI":"10.4049\/jimmunol.175.10.6764","article-title":"Absence of thrombin-activatable fibrinolysis inhibitor protects against sepsis-induced liver injury in mice","volume":"175","author":"Renckens","year":"2005","journal-title":"J Immunol"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0045","doi-asserted-by":"crossref","first-page":"51059","DOI":"10.1074\/jbc.M306977200","article-title":"Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammation","volume":"278","author":"Myles","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0050","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1348-0421.2002.tb02669.x","article-title":"Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N","volume":"46","author":"Campbell","year":"2002","journal-title":"Microbiol Immunol"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0055","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.thromres.2005.06.007","article-title":"TAFI and PAI-1 levels in human sepsis","volume":"118","author":"Zeerleder","year":"2006","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0049-3848(01)00331-0","article-title":"Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation","volume":"104","author":"Watanabe","year":"2001","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0065","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1055\/s-2004-815625","article-title":"The impact of single nucleotide polymorphisms of the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI antigen levels in healthy children and pediatric oncology patients","volume":"29","author":"Knoefler","year":"2003","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0070","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1160\/TH04-07-0454","article-title":"Carboxypeptidase U (TAFIa): a metallocarboxypeptidase with a distinct role in haemostasis and a possible risk factor for thrombotic disease","volume":"94","author":"Leurs","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0075","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1097\/01.CCM.0000072121.61120.D8","article-title":"Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study","volume":"31","author":"De Kleijn","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0080","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1007\/s00134-002-1505-1","article-title":"Procalcitonin as a prognostic marker in meningococcal disease","volume":"28","author":"Van Der Kaay","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0085","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1097\/01.CCM.0000171272.50888.AD","article-title":"Serum lipids and disease severity in children with severe meningococcal sepsis","volume":"33","author":"Vermont","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0090","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1210\/jcem.87.7.8605","article-title":"Acute stress response in children with meningococcal sepsis: important differences in the growth hormone\/insulin-like growth factor I axis between nonsurvivors and survivors","volume":"87","author":"De Groof","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0095","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1210\/jc.2005-1107","article-title":"Adrenal insufficiency in meningococcal sepsis: bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality","volume":"90","author":"Den Brinker","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0100","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/515184","article-title":"Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. European Pediatric Meningococcal Septic Shock Trial Study Group","volume":"28","author":"Derkx","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","article-title":"International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics","volume":"6","author":"Goldstein","year":"2005","journal-title":"Pediatr Crit Care Med"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0110","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1086\/513759","article-title":"Meningococcal septic shock in children: clinical and laboratory features, outcome, and development of a prognostic score","volume":"25","author":"Kornelisse","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0115","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/00003246-198811000-00006","article-title":"Pediatric risk of mortality (PRISM) score","volume":"16","author":"Pollack","year":"1988","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0120","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","article-title":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation","volume":"86","author":"Taylor","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0125","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1128\/jcm.33.12.3326-3327.1995","article-title":"Comparison of commercial diagnostic tests for identification of serogroup antigens of Neisseria meningitidis","volume":"33","author":"Van Der Ende","year":"1995","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0130","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1161\/01.ATV.0000199246.08616.98","article-title":"Development of ELISAs measuring the extent of TAFI activation","volume":"26","author":"Ceresa","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0135","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1186\/cc4836","article-title":"CC and CXC chemokine levels in children with meningococcal sepsis accurately predict mortality and disease severity","volume":"10","author":"Vermont","year":"2006","journal-title":"Crit Care"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0140","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/bmj.312.7038.1079","article-title":"Transformations, means, and confidence intervals","volume":"312","author":"Bland","year":"1996","journal-title":"BMJ"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0145","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1097\/01.PCC.0000161947.57506.D6","article-title":"Diagnosing meningococcemia as a cause of sepsis","volume":"6","author":"Hazelzet","year":"2005","journal-title":"Pediatr Crit Care Med"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0150","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJM200006153422406","article-title":"Plasminogen-activator inhibitor type 1 and coronary artery disease","volume":"342","author":"Kohler","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0155","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/PL00000615","article-title":"The plasminogen activator system: biology and regulation","volume":"56","author":"Irigoyen","year":"1999","journal-title":"Cell Mol Life Sci"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0160","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s004310050958","article-title":"Pathophysiology of meningococcal sepsis in children","volume":"157","author":"De Kleijn","year":"1998","journal-title":"Eur J Pediatr"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0165","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1128\/IAI.66.11.5350-5356.1998","article-title":"Complement activation in relation to capillary leakage in children with septic shock and purpura","volume":"66","author":"Hazelzet","year":"1998","journal-title":"Infect Immun"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0170","doi-asserted-by":"crossref","DOI":"10.1186\/cc6161","article-title":"Improved survival of children with sepsis and purpura: effects of age, gender, and era","volume":"11","author":"Maat","year":"2007","journal-title":"Crit Care"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0175","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00277-005-1079-4","article-title":"Plasma antigen levels of thrombin-activatable fibrinolysis inhibitor did not differ in patients with or without disseminated intravascular coagulation","volume":"84","author":"Chen","year":"2005","journal-title":"Ann Hematol"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0180","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1074\/jbc.M104444200","article-title":"Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme","volume":"277","author":"Schneider","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0185","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/j.1538-7836.2005.01388.x","article-title":"A new functional assay of thrombin activatable fibrinolysis inhibitor","volume":"3","author":"Guimaraes","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0190","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1538-7836.2004.00557.x","article-title":"A functional single nucleotide polymorphism in the thrombin-activatable fibrinolysis inhibitor (TAFI) gene associates with outcome of meningococcal disease","volume":"2","author":"Kremer Hovinga","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.02841.x_bb0195","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s001340050903","article-title":"Why immunomodulatory therapies have not worked in sepsis","volume":"25","author":"Abraham","year":"1999","journal-title":"Intensive Care Med"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2008.02841.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622129491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622129491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2008.02841.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:44:50Z","timestamp":1761533090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622129491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":38,"aliases":["10.1111\/j.1538-7836.2007.02841.x"],"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S1538783622129491"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2008.02841.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombin activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2008.02841.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}